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Abstract
A simple, highly sensitive method to detect leukemia cells has been developed based on aptamer-modified fluorescent
silica nanoparticles (FSNPs). In this strategy, the amine-labeled Sgc8 aptamer was conjugated to carboxyl-modified FSNPs
via amide coupling between amino and carboxyl groups. Sensitivity and specificity of Sgc8-FSNPs were assessed using
flow cytometry and fluorescence microscopy. These results showed that Sgc8-FSNPs detected leukemia cells with high
sensitivity and specificity. Aptamer-modified FSNPs hold promise for sensitive and specific detection of leukemia cells.
Changing the aptamer may allow the FSNPs to detect other types of cancer cells.
Background
Leukemia is a common, aggressive cancer that seriously
affects blood cells, the lymphatic system, and the bone
marrow [1, 2]. It seriously interferes with daily activities
and increases the risk of death [3]. Immediate treatment
is critical for improving the survival rate of patients with
leukemia [4], highlighting the need for early diagnosis
using sensitive and specific methods.
Current methods to detect leukemia cells usually rely
on various cytochemical analyses of peripheral blood
cells and bone marrow, including karyotyping [5], flow
cytometry-based immunophenotyping [6], microarrays
[7], cell enrichment [8], polymerase chain reaction [9],
and electrochemical sensors [10]. These methods have
various limitations, such as low sensitivity, high cost, and
high complexity. Thus, a simple, highly sensitive method
is urgently needed to detect leukemia cells.
A technology that shows promise in this regard is fluor-
escent silica nanoparticles (FSNPs), which are superior to
organic dye probes [11]. FSNPs easily undergo surface
modifications, and they show good biocompatibility [12].
On the other hand, FSNPs by themselves are not selective
for cancerous tissue, so researchers have turned to apta-
mers to confer specificity and selectivity on FSNPs biodis-
tribution and activity.
Aptamers are single-stranded nucleic acids selected
from random-sequence libraries of DNA or RNA
through an in vitro selection process called systematic
evolution of ligands by exponential enrichment (SELEX)
[13]. The resulting sequences can bind a wide range of
targets with high affinity, including small molecules [14,
15], proteins [16], and even whole cells [17]. Numerous
studies have shown that aptamer-functionalized FSNPs
can target many types of cancer [18–20]. These results
suggest that aptamer-FSNPs may allow reliable identifi-
cation of leukemia cells.
Here, we design and prepare FSNPs modified with the
aptamer Sgc8, which binds tightly and specifically to T
acute lymphocytic leukemia cells. The resulting Sgc8-
FSNPs were analyzed by dynamic light scattering,
transmission electron microscopy (TEM), zeta potential
measurement, Fourier transform infrared (FT-IR) spec-
troscopy, ultraviolet–visible (UV–vis) spectroscopy, and
fluorimetry. Their ability to detect leukemia cells was
assessed using flow cytometry and fluorescence micros-
copy. Their toxicity was evaluated in vitro and in vivo
using the CKK-8 assay and histology of organ sections.
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Our results suggest that this novel probe may be a
reliable and efficient way to detect leukemia cells.
Methods
Materials
Fluorescein isothiocyanate (FITC), 3-aminopropylmethyldi
methoxysilane (APTMS), Triton X-100, n-hexanol, cyclo-
hexane, tetraethyl orthosilicate (TEOS), ammonium hy-
droxide (NH4OH, 25-28 wt %), 1-ethyl-3-(3-dimethylamino
propyl)carbodiimide hydrochloride (EDC), N-hydroxysulfo-
succinimide sodium salt (sulfo-NHS), and N-[(3-trimethox-
ysilyl)propyl]ethylenediamine triacetic acid trisodium salt
(TMS-EDTA) were bought from Sigma Chemical (St.
Louis, MO, USA). DNA oligonucleotides were synthesized
by Shanghai Sangon Biological Engineering Technology &
Services (Shanghai, China). These oligonucleotides included
the amine-labeled Sgc8 aptamer (Sgc8), 5′-NH2-TTTTTT
TTTTATCTAACTGCTGCGCCGCCGGGAAAATACTG




A mixture of FITC in anhydrous ethanol (1 mg/l, 1 ml)
and APTMS (10 μl) was stirred for 24 h to prepare
FITC-APTMS. FSNPs were prepared as a water-in-oil
microemulsion in a solution containing 7.5 ml of cyclo-
hexane, 1.6 ml of n-hexanol, 1.77 ml of Triton X-100,
and 500 μl of distilled water. This solution was stirred
for 30 min at room temperature, and then 150 μl of
FITC-APTMS, 100 μl of TEOS, and 60 μl of NH4OH
were successively added, after which the solution was
stirred for another 24 h. Then 30 μl of NTTS was added,
and the mixture was stirred for another 24 h. The result-
ing carboxyl-modified FSNPs (FSNPs-COOH) were pre-
cipitated in an equal volume of acetone and collected by
alternately centrifuging and washing three times with
deionized water and fresh 95 % ethanol.
Amine-labeled Sgc8 was cross-linked to FSNPs-COOH
using EDC as follows. Briefly, FSNPs-COOH (ca. 0.1 mg,
1 ml) were washed in MES buffer (0.1 M, pH 5.65) and
resuspended in 950 μl of MES buffer (0.1 M, pH 5.65).
This solution was added with 50 μl of 10 μM amine-
labeled Sgc8, 1.8 mg of EDC, and 3.5 mg of sulfo-NHS,
after which the mixture was shaken gently for 3 h at room
temperature. The nanoparticles were washed three times
with PBS (0.1 M, pH 7.4) and incubated with 0.05 % BSA
in PBS for 1 h at room temperature to block free carboxyl
groups. Sgc8-FSNPs were collected by three rounds of
centrifugation and resuspension in PBS and then stored
at 4 °C in MES buffer (0.1 M, pH 5.65) containing 1 %
BSA until use.
Characterization of Sgc8-FSNPs
The structural features of Sgc8-FSNPs were analyzed
using TEM (H-7650, Japan), while average size and zeta
potential were determined using dynamic light scattering
on a Zetasizer Nano instrument (Malvern Instruments,
UK). The modification of surface carboxyl and amino
groups on FSNPs was confirmed using FT-IR spectroscopy
(Nicolet-5700, USA). The UV–vis absorption spectrum was
obtained (UV 2550, Shimadzu, Japan), as well as fluores-
cence emission spectrum (Hitachi F-4600, Japan). For all
these measurements, a concentration of 0.1 mg/ml Sgc8-
FSNPs was used.
The number of moles of FSNPs was calculated using
the method of Pang et al. [12], and the average number
of aptamers on the nanoparticle surface was estimated
based on fluorescence signal as follows. Briefly, initial
fluorescence intensity (I1) was measured immediately after
mixing FITC-Sgc8 with FSNPs-COOH. When amide coup-
ling of FITC-Sgc8 to FSNPs-COOH via the carboxyl and
amino groups was complete, the supernatant was washed
to remove unbound FITC-Sgc8, and the fluorescence inten-
sity (I2) of the resuspension was measured. The ratio I2/I1
was taken to indicate the efficiency of aptamer modification
on the surface of FSNPs. Then the amount of Sgc8 on
FSNPs was calculated by taking the actual number of
FITC-Sgc8 molecules on FSNPs and dividing by the num-
ber of FSNPs.
Cells and Animals
Cell lines were obtained from the National Center for
International Research of Biological Targeting Diagnosis
and Therapy of Guangxi Medical University. CCRF-
CEM cells (human acute lymphoblastic leukemia, T cell)
as a positive control for leukemia cells and Ramos cells
(human Burkitt’s lymphoma, B cell) as a negative control
were cultured in 1640 medium supplemented with 10 %
fetal bovine serum (FBS, Hyclone) and 100 U/ml
penicillin-streptomycin. Both cell lines were incubated
with Sgc8-FSNPs. In a separate experiment, L-02 and
293T cells were incubated with Sgc8-FSNPs to evaluate
their cytotoxicity. These two cell lines were cultured in
DMEM medium supplemented with 10 % FBS and
100 U/ml penicillin-streptomycin.
Six-week-old female BALB/c nude mice from the
Guangxi Laboratory Animal Center (Guangxi, China)
were raised in sterile conditions in a laminar flow hood.
All protocols were conducted in accordance with the
guidelines of the Animal Ethics Committee of Guangxi
Medical University, Nanning, Guangxi, China.
Flow Cytometry
Cells were cultured at a density of 3.0 × 105 cells/ml, col-
lected by centrifugation, and resuspended in 200 μl of
PBS. Then cells were incubated on ice for 30 min in the
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dark with Sgc8-FSNPs, FSNPs, or FITC-Sgc8 in 200 μl
of cell culture medium or binding buffer (PBS supple-
mented with 5 mM MgCl2, 4.5 g/l glucose, and 1 mg/ml
BSA). Cells were washed with PBS, suspended in 200 μl
of binding buffer and analyzed by flow cytometry
(Beckman Coulter Epics XL, USA). Data were analyzed
using EXPO32 ADC Analysis software.
Cell Imaging
CCRF-CEM and Ramos cells were cultured for 12 h in
six-well dishes at a density of 3 × 105 cells per well. Cells
were washed three times with PBS and incubated with
Sgc8-FSNPs, FSNPs, or FITC-Sgc8, respectively, in binding
buffer on ice for 30 min in the dark. Cells were washed
three times with PBS, fixed with 4 % polyoxymethylene
(Sigma-Aldrich) for 20 min, and stained with 4′, 6-
diamidino-2-phenylindole dihydrochloride (DAPI; Life Co.,
USA) for 5 min in the dark. Finally, cells were washed
three times with PBS and examined by fluorescence
microscopy (Nikon DS-Ri1, Japan).
In Vitro and In Vivo Toxicity of Sgc8-FSNPs
Two types of normal cells, such as L-02 and 293T cells,
were cultured for 24 h in 96-well plates at an initial
density of 1.0 × 104 cells/well and then exposed to Sgc8-
FSNPs at 0.1, 0.5, or 1.0 mg/ml for 8, 16, and 24 h. Cyto-
toxicity of the treatments was assessed using the CCK-8
assay [21]. At the specific time points, the culture medium
was removed and cells were washed three times with PBS.
Then 10 μl of CCK-8 solution was added to each well in
90 μl of serum-free DMEM medium. After incubation for
4 h at 37 °C, the absorbance of each well at 450 nm was
measured using a Bio-Rad microplate reader (DTX880,
Beckman Coulter, USA).
To examine the in vivo toxicity of Sgc8-FSNPs, nude
mice received a single tail vein injection of 200 μl of PBS
(control group) or PBS containing Sgc8-FSNPs, FSNPs, or
FITC-Sgc8 (1 mg/ml). At 1 week after injection, mice were
sacrificed, and sections of major tissues (heart, lung, liver,
spleen, kidney) were immersed in 10 % formaldehyde
solution, dehydrated, and paraffin-embedded. Serial sec-
tions (4 μm) were cut and stained with hematoxylin-eosin.
Statistical Analyses
Each experiment was carried out in triplicate. Data were
expressed as mean ± SD or as median (range). All statis-
tical analyses were performed using GraphPad Prism
(GraphPad Software, San Diego, CA, USA). P < 0.05 was
considered the threshold of significance in all analyses.
Results and Discussion
In this present study, we combined the Sgc8 aptamer,
developed through live-cell SELEX to bind tightly and spe-
cifically to CCRF-CEM cells [22], with FSNPs as a signal
reporter in order to develop a novel detection probe for
leukemia (Fig. 1). The combination of specific targeting by
Sgc8 and the strong fluorescence, photostability, and
biocompatibility of FSNPs [11] may make Sgc8-FSNPs a
clinically useful reagent in the fight to diagnose leukemia as
early as possible to ensure timely treatment.
Fig. 1 Schematic illustration of Sgc8 aptamer-modified FSNPs for highly sensitive detection of leukemia cells
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Characterization of Sgc8-FSNPs
The reverse microemulsion method is widely used to
prepare silica nanoparticles, because it can yield uni-
form, monodisperse particles [23], and our FSNPs were
indeed uniform in shape and size (Fig. 2a, panels a and
b). Average diameter was 70.52 ± 2.64 nm for FSNPs
and 75.18 ± 2.89 nm for Sgc8-FSNPs; the corresponding
zeta potentials were −31.21 ± 2.75 mV and −37.57 ±
3.33 mV (Table 1). The more negative zeta potential for
Sgc8-FSNPs than FSNPs (Fig. 2b) likely reflects the
additional negative charge of the phosphate groups on
the DNA aptamer [24]. The efficiency of aptamer con-
jugation onto the surface of FSNPs was determined
indirectly from the change in fluorescence intensity
during the reaction between FITC-Sgc8 and SNPs.
Based on the conversion that 1 mg of SNPs with an
average diameter of about 60 nm is approximately
6.8 pmol [12], and assuming that the initial number of
aptamers was 500 pmol and the conjugation efficiency
was 43 %, we estimated that the surface of our FSNPs
contained approximately 420 aptamers (Table 1).
The FT-IR spectra of Sgc8, FSNPs, and Sgc8-FSNPs
are shown in Fig. 2c. The spectrum for Sgc8-FSNPs
showed peaks at 1658 cm−1 (C=O carbonyl stretching
vibrations), 1554 cm−1 (C–N stretching vibrations and
N–H bending), and 1100 cm−1 (Si–O stretching
vibrations). The feature of amides II was observed
around 1554 cm−1 originated from C–N stretching vi-
brations and N–H bending [25]. The peak at 1554 cm−1
was observed at the spectrum for Sgc8-FSNPs, so it
likely reflects the attachment of the amine-labeled apta-
mer Sgc8 to the surface of FSNPs-COOH.
Figure 2d shows the UV–vis absorbance spectrum
(solid line) and fluorescence emission spectrum (dashed
line) of FSNPs before and after aptamer conjugation.
The UV–vis spectrum of Sgc8-FSNPs showed a DNA
absorbance peak at 260 nm that was absent from the
spectrum of FSNPs, suggesting that the aptamer had indeed
conjugated with the nanoparticles. The fluorescence emis-
sion spectra of both FSNPs and Sgc8-FSNPs showed a peak
at 520 nm, corresponding to FITC. This indicates that apta-
mer addition does not change the fluorescence properties of
FSNPs [26].
These results of characterization of Sgc8-FSNPs indicate
that we successfully conjugated aptamer to the surface of
FSNPs.
Flow Cytometric Detection of Leukemia Cells
At first, the ability of Sgc8-FSNPs to detect leukemia
cells was investigated by flow cytometry. Ramos cells
were used as negative cells, and FSNPs were used as
control probe. For the detection of CCRF-CEM cells,
Fig. 2 Characterization of Sgc8-FSNPs. a Particle size distribution of a Sgc8-FSNPs based on dynamic light scattering. b TEM of Sgc8-FSNPs.
b Zeta potential of Sgc8, FSNPs, and Sgc8-FSNPs. c FT-IR spectra of Sgc8, FSNPs, and Sgc8-FSNPs. d UV–vis absorbance (solid line) and
fluorescence emission spectra (dashed line) of FSNPs before and after modification with Sgc8
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stronger fluorescence intensity was observed on Sgc8-
FSNPs than FITC-Sgc8, while no fluorescence signal was
found on FSNPs (Fig. 3a, panel a). In addition, no obvi-
ous fluorescence signal was observed on Ramos cells
after incubation with Sgc8-FSNPs, FITC-Sgc8, and
FSNPs, respectively (Fig. 3a, panel b). Similar results
were obtained by statistical graph of the binding rate of
CEM and Ramos cells (Fig. 3b, panels a and b). These
results suggested that Sgc8-FSNPs can be used to detect
CEM cells with higher sensitivity than FITC-Sgc8.
Fluorescence Microscopy
To confirm whether the synthesized Sgc8-FSNPs can
recognize and bind CEM cells, fluorescence microscopy
images were performed with the same brightness and
contrast. As shown in Fig. 4a, both Sgc8-FSNPs and
FITC-Sgc8 stained surface of CCRF-CEM cells with
green fluorescence, while FSNPs did not. Stronger green
fluorescence was also observed on Sgc8-FSNPs than
FITC-Sgc8 (Fig. 4a). Consistent with the analysis of flow
cytometry, no green fluorescence was found on the sur-
face of Ramos cells after incubation with Sgc8-FSNPs,
FITC-Sgc8, and FSNPs, respectively (Fig. 4b). So, we can
agree that Sgc8-FSNPs specially recognize and bind
CEM with high sensitivity, which is attributed to the
interaction between aptamer and its targeting cells ra-
ther than the nonspecific binding between FSNPs and
cells. In addition, the fluorescence signal of Sgc8-FSNPs
is stronger than FITC-Sgc8, which is caused by fluores-
cent signal amplification of FSNPs.
Photostability of Sgc8-FSNPs and FITC-Sgc8
To confirm the anti-photobleaching property of FITC
dyes doped inside the silica matrix, fluorescence mi-
croscopy was also used to assess the photostability of
Sgc8-FSNPs and FITC-Sgc8. Samples were illuminated
continuously with a 488-nm laser for 10 min, and
fluorescent images were taken at 0, 1, 5, and 10 min.
Fluorescence intensity was quantitated using Image
Pro (Media Cybernetics, Bethesda, MD, USA). Fluores-
cence intensity was stronger for Sgc8-FSNPs than for
FITC-Sgc8. Normalized fluorescence intensity was also
Table 1 Size, zeta potential, and surface charge characteristics
of FSNPs and Sgc8-FSNPs
Sample Size (nm) Zeta (mV) Aptamer-FSNPs
FSNPs 70.52 ± 2.64 −31.21 ± 2.75 –
Sgc8-FSNPs 75.18 ± 2.89 −37.57 ± 3.33 419.92 ± 39.83
Fig. 3 Flow cytometric detection of leukemia cells. a Sgc8-FSNPs, FITC-Sgc8, or FSNPs were mixed with a CCRF-CEM cells or b Ramos cells.
b Statistical graph for rates of binding to a CCRF-CEM cells and b Ramos cells by Sgc8-FSNPs, FITC-Sgc8, or FSNPs. NS, not significant.
**P < 0.01, ***P < 0.001
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Fig. 4 Fluorescence micrographs of CCRF-CEM and Ramos cells after mixing with Sgc8-FSNPs, FITC-Sgc8, or FSNPs. a CCRF-CEM cells after incubation.
b Ramos cells after incubation. Nuclei were stained with DAPI and examined in the blue channel, while FSNPs and FITC were examined in the green
channel. The blue and green channels were combined in the merged images
Fig. 5 Fluorescence images and quantitation of photostability of Sgc8-FSNPs and FITC-Sgc8
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compared between Sgc8-FSNPs and FITC-Sgc8. In-
tense irradiation for 10 min reduced the fluorescence
intensity of Sgc8-FSNPs by only 18 %, while the fluor-
escence intensity of FITC-Sgc8 fell by 74 %. This sug-
gests that Sgc8-FSNPs were more photostable than
FITC-Sgc8. The reason may be explained by FITC mol-
ecules well doped the silica shell that separate potential
quenching substance from dye molecules through elec-
trostatic interaction [12, 27–29] (Fig. 5).
In Vitro and In Vivo Toxicity of Sgc8-FSNPs
In vitro cytotoxicity of Sgc8-FSNPs was evaluated in the
normal cell lines 293T and L-02. Both cell lines showed
high viability, based on the CCK-8 assay, after incubation
with various concentrations of Sgc8-FSNPs (Fig. 6a, panels
a and b). This suggests that Sgc8-FSNPs show minimal
cytotoxicity. We tested this in vivo by treating nude mice
with Sgc8-FSNPs and then examining tissue sections from
major organs after staining with hematoxylin-eosin. No
obvious signs of necrosis or inflammation were observed,
confirming that Sgc8-FSNPs show minimal toxic effects
(Fig. 6b). This justifies further animal and potentially hu-
man testing of Sgc8-FSNPs as a diagnostic probe in the
clinic. However, FSNPs show short half-life in the circula-
tory system, the aptamer is vulnerable to degradation, and
the release of fluorescent dye into the blood may
increase the risk of systemic toxicity [18]. So, further
studies should minimize these limitations for in vivo
biological applications.
Our work adds to a growing literature demonstrating the
power of aptamer-nanoparticles conjugation for the detec-
tion and treatment of cancer. Such conjugates have been
used to collect and image leukemia cells [30], detect cancer
cells in whole blood [31], create a “super sandwich” cyto-
sensor of aptamer-quantum dots to detect cancer cells [32],
target and deliver daunorubicin to leukemia cells [33], and
target CEM cells for controlled drug delivery [34]. The
present study extends this literature by determining the
amount of aptamer on nanoparticles, showing sensitive and
specific detection of CCRF-CEM cells over Ramos cells,
and evaluating the in vivo toxicity of Sgc8-FSNPs.
Conclusions
In summary, we have designed a simple, highly sensitive,
and specific aptamer-modified FSNPs system for detecting
leukemia cells. The usefulness of this system lies in the
strong, specific target binding by the aptamer, as well as the
fluorescence signal amplification due to the high density of
FITC fluorophore in the nanoparticles. This system may
prove useful not only for the diagnosis of leukemia but also
for the targeted delivery of anti-leukemia drugs. In addition,
it may be adaptable to other types of cancer through the
selection of appropriate aptamers.
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